Reduction in 3-Year Risk of Death or Lung Transplant for Individuals with Advanced Cystic Fibrosis Lung Disease Treated with Elexacaftor/Tezacaftor/Ivacaftor.
Allison J Love, Sameer Desai, Stephanie Y Cheng, Anne L Stephenson, Sanja Stanojevic, Alessandro N Franciosi, Bradley S Quon
{"title":"Reduction in 3-Year Risk of Death or Lung Transplant for Individuals with Advanced Cystic Fibrosis Lung Disease Treated with Elexacaftor/Tezacaftor/Ivacaftor.","authors":"Allison J Love, Sameer Desai, Stephanie Y Cheng, Anne L Stephenson, Sanja Stanojevic, Alessandro N Franciosi, Bradley S Quon","doi":"10.1513/AnnalsATS.202405-451RL","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":93876,"journal":{"name":"Annals of the American Thoracic Society","volume":" ","pages":"302-305"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the American Thoracic Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1513/AnnalsATS.202405-451RL","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
